2022 American Transplant Congress
Current State of Use of Hepatitis C Viremic Donor Organs in Negative Recipients in the United States: A National Survey
*Purpose: Since the advent of direct-acting antiviral (DAA) therapy, use of hepatitis C (HCV) viremic donor organs in HCV negative recipients has become more common.…2022 American Transplant Congress
Correction of Hyperoxaluria in a Primary Hyperoxaluria Type 2 Patient After Simultaneous Liver Kidney Transplantation
Nephrology and Hypertension, Mayo Clinic, Rochester, MN
*Purpose: To demonstrate the role of simultaneous liver kidney transplant in PH2*Methods: A 30-year-old white man presented to our center for evaluation of chronic kidney…2022 American Transplant Congress
Impact of a Transplant Pharmacy Collaborative Practice Agreement Implementation on an Institutional Medication Assistance Program Funding Utilization
*Purpose: Post-transplant medication cost can pose a significant barrier for patient adherence and graft outcomes. Strategic selection of medication agent is often challenging and requires…2022 American Transplant Congress
Post-Allocation Policy and Changes in Gender Disparities in Access to Simultaneous Liver and Kidney Transplantation
*Purpose: Gender-based differences in receiving simultaneous liver-kidney transplant (SLKT) is not well-understood. We recently found that women are disadvantaged in access to SLKT, especially women…2022 American Transplant Congress
Barriers to Completing the Transplant Evaluation Process: A Mixed-Methods Study
*Purpose: Little is known about patient-reported factors affecting patients’ access to the kidney transplant waitlist after starting evaluation. We qualitatively assessed patients’ perceived barriers to…2022 American Transplant Congress
Simultaneous Liver-Kidney Transplantation is Accompanied by Significant Return of Native Renal Function as Demonstrated by Mag3 Scan
Cleveland Clinic, Cleveland, OH
*Purpose: Simultaneous liver-kidney transplant (SLK) has become an increasingly popular option due to commonly comorbid renal insufficiency in liver failure,. Following SLK, it is unknown…2022 American Transplant Congress
Understanding the Impact of Financial Obstacles and Reimbursement for Lost Wages on the Decision-Making Process for Living Organ Donation
*Purpose: This study examined the impact of financial obstacles (e.g., lost wages, travel, and dependent care expenses) on the decision to initiate an evaluation for…2022 American Transplant Congress
Pulsatile Kidney Perfusion Improves Survival and Graft Function in High Acuity Combined Liver Kidney Transplant (CLKT) Recipients
*Purpose: Due to underlying renal dysfunction, CLKT recipients tend to have higher medical acuity at baseline resulting in a higher likelihood of post-operative complications and…2022 American Transplant Congress
The Prevalence And Risk Factors Of De Novo Hepatitis B Virus Infection In Kidney Transplantation From Hepatitis B Antigen-positive Donors To Hbsag-negative Recipients
1urology, west china hospital, Chengdu, China, 2Urology, West China Hospital, Chengdu, China
*Purpose: To explore the prevalence and risk factors of de novo HBV infection (DNH) in kidney transplantation (KT) from HBsAg⁺ donors (D[HBsAg⁺]) to HBsAg-negative recipients…2021 American Transplant Congress
Effect of Defibrotide on Kidney Ischemia Reperfusion Injury in a Preclinical Renal Transplant Model
*Purpose: Ischemia reperfusion injury (IRI) is a major contributor to graft failure. During organ removal and preservation, ischemia results in anaerobic respiration and cellular damage.…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 24
- Next Page »